ATE347896T1 - Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion - Google Patents
Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktionInfo
- Publication number
- ATE347896T1 ATE347896T1 AT01956170T AT01956170T ATE347896T1 AT E347896 T1 ATE347896 T1 AT E347896T1 AT 01956170 T AT01956170 T AT 01956170T AT 01956170 T AT01956170 T AT 01956170T AT E347896 T1 ATE347896 T1 AT E347896T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- vitamins
- cardiovascular function
- improving cardiovascular
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000009084 cardiovascular function Effects 0.000 title 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- 235000015097 nutrients Nutrition 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- 229940088594 vitamin Drugs 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 abstract 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22152600P | 2000-07-28 | 2000-07-28 | |
| US09/677,639 US6429198B1 (en) | 1999-04-12 | 2000-10-03 | Compositions for increasing athletic performance in mammals |
| US30220001P | 2001-06-29 | 2001-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347896T1 true ATE347896T1 (de) | 2007-01-15 |
Family
ID=27396950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01956170T ATE347896T1 (de) | 2000-07-28 | 2001-07-27 | Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1313488B1 (de) |
| JP (1) | JP2004505056A (de) |
| CN (1) | CN1299690C (de) |
| AT (1) | ATE347896T1 (de) |
| AU (1) | AU2001278197A1 (de) |
| DE (1) | DE60125191T2 (de) |
| ES (1) | ES2275703T3 (de) |
| WO (1) | WO2002009727A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2004019926A1 (ja) * | 2002-08-30 | 2005-12-15 | 三菱ウェルファーマ株式会社 | 心不全の予防及び／又は治療剤 |
| JP5065570B2 (ja) * | 2002-09-06 | 2012-11-07 | 第一三共ヘルスケア株式会社 | 血管内皮性酸化窒素の合成促進剤 |
| JP2007106703A (ja) * | 2005-10-14 | 2007-04-26 | Nutri Kk | 血管障害の予防および治療組成物 |
| GB0607402D0 (en) | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| WO2007129618A1 (ja) * | 2006-05-08 | 2007-11-15 | National University Corporation Kagawa University | 好中球の活性化および遊走因子の抑制剤およびその利用 |
| US8835396B2 (en) * | 2006-12-15 | 2014-09-16 | Bioenergy, Inc. | Method and compositions for improving pulmonary hypertension |
| WO2009065142A2 (en) * | 2007-11-15 | 2009-05-22 | Biomedical Research Foundation Of Northwest Louisiana | Use of nitrite salts in chronic ischemia |
| WO2009094593A1 (en) * | 2008-01-25 | 2009-07-30 | Foker John E | Methods and compositions for inhibiting progression to chronic cardiac failure |
| US20100055206A1 (en) * | 2008-04-02 | 2010-03-04 | St Cyr John A | Use of ribose in first response to acute myocardial infarction |
| IT1391588B1 (it) * | 2008-10-15 | 2012-01-11 | Giellepi Chemicals S P A | Composizione sinergica per il recupero e la riduzione del danno ischemico lieve |
| GB201223365D0 (en) * | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
| US20170340584A1 (en) * | 2014-12-16 | 2017-11-30 | Jonghyun BYUN | Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same |
| KR101666913B1 (ko) * | 2014-12-23 | 2016-10-17 | 변종현 | 당 및 타우린을 포함하는 대사질환 예방 또는 치료용 약학조성물 |
| CN109998101A (zh) * | 2019-01-28 | 2019-07-12 | 天津星宇航天生物科技有限公司 | 一种适用心脏调养人群的宇航民用营养配方 |
| CN110664824B (zh) * | 2019-08-09 | 2021-01-01 | 北京佳博泰和健康科技有限公司 | 一种营养支持剂及其制备方法和用途 |
| CN114209709A (zh) * | 2021-12-16 | 2022-03-22 | 海门品尚医药科技有限公司 | D-核糖在制备改善药物性心脏毒性药物或食品中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
| JPH02286620A (ja) * | 1989-04-27 | 1990-11-26 | Riide Chem Kk | 抗高脂血症用剤 |
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| US5707971A (en) * | 1995-06-07 | 1998-01-13 | Life Resuscitation Technologies, Inc. | Modulation of glycolytic ATP production |
| US6218366B1 (en) * | 1998-06-19 | 2001-04-17 | Bioenergy, Inc. | Method for raising the hypoxic threshold |
| US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
| US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
-
2001
- 2001-07-27 AU AU2001278197A patent/AU2001278197A1/en not_active Abandoned
- 2001-07-27 WO PCT/US2001/041448 patent/WO2002009727A1/en active IP Right Grant
- 2001-07-27 AT AT01956170T patent/ATE347896T1/de active
- 2001-07-27 JP JP2002515280A patent/JP2004505056A/ja active Pending
- 2001-07-27 EP EP01956170A patent/EP1313488B1/de not_active Expired - Lifetime
- 2001-07-27 CN CNB018135226A patent/CN1299690C/zh not_active Expired - Lifetime
- 2001-07-27 ES ES01956170T patent/ES2275703T3/es not_active Expired - Lifetime
- 2001-07-27 DE DE60125191T patent/DE60125191T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1313488B1 (de) | 2006-12-13 |
| AU2001278197A1 (en) | 2002-02-13 |
| CN1454090A (zh) | 2003-11-05 |
| EP1313488A1 (de) | 2003-05-28 |
| DE60125191D1 (de) | 2007-01-25 |
| EP1313488A4 (de) | 2005-11-30 |
| JP2004505056A (ja) | 2004-02-19 |
| WO2002009727A1 (en) | 2002-02-07 |
| ES2275703T3 (es) | 2007-06-16 |
| CN1299690C (zh) | 2007-02-14 |
| DE60125191T2 (de) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60125191D1 (de) | Zusammensetzungen und methoden zur verbesserung der kardiovaskulären funktion | |
| EP2769715A3 (de) | Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien | |
| WO2006112716A3 (en) | Nutritional supplement for hiv patients | |
| WO2006068697A3 (en) | Compositions including iron | |
| MX2007007781A (es) | Composiciones cardiovasculares. | |
| SG163600A1 (en) | Methods for the treatment of muscle loss | |
| ATE293974T1 (de) | Pharmazeutische zusammensetzungen zur unbehagenverminderung | |
| WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
| WO2003038123A3 (en) | Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene | |
| WO2005017192A3 (en) | Screening for gestational disorders | |
| SG151327A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| EP2241196A3 (de) | Oligosaccharide und Zysteine enthaltendes Nahrungsergänzungsmittel zur behandlung von hiv | |
| BR0315169A (pt) | Referência cruzada a pedidos de patente relacionados | |
| WO2005058961A3 (en) | Antibodies specific for human galanin, and uses thereof | |
| WO2005079396A3 (en) | O,o'-amidomalonate and n,o-amidomalonate platinum complexes | |
| WO2005023185A3 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| PT1411960E (pt) | Produto alimentar enriquecido a base de farelo de arroz para promocao da saude cardiovascular | |
| ATE329601T1 (de) | Medizinische zusammensetzungen zur behandlung oder vorbeugung eines funktionellen vitamin b12 mangels | |
| UA90893C2 (ru) | Пероральная дозированная форма производных гемцитабина | |
| PL1708711T3 (pl) | Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu | |
| WO2003068231A3 (de) | Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung | |
| SI1838716T1 (sl) | Olanzapin pamoat dihidrat | |
| BRPI0413618B8 (pt) | xarope multivitamínico para crianças ou adolescentes | |
| HUP0401633A2 (hu) | Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1313488 Country of ref document: EP |